Genomadix’s Post

📰This study aimed to explore the status and diagnostic value of initial aPL testing in all patients with acute ischemic stroke. READ➡️https://lnkd.in/eJ2K3EqM

In this single-center prospective case-control study, the findings illuminate the association between thromboembolism, pyoderma gangrenosum, and subsequent wound healing outcomes. https://ja.ma/3HXIesL

Medical records were used to identify the prevalence of Mast Cell Activation Syndrome (MCAS) among those with Ehlers-Danlos Syndrome (EDS) and Postural Orthostatic Tachycardia Syndrome (POTS). The results of this study were truly surprising (infographic below). The reason for extensive diagnostic overlap among the three syndromes remains unclear to medical professionals. We at the Brain Inflammation Collaborative are on a mission to help researchers better understand this relationship so it becomes widely understood, promptly diagnosed, and treated. Join us by sharing this content! Study: https://lnkd.in/gr24_3TW #EDS #MCAS #POTS

Ongoing research is highlighting the benefits of blocking IFN signaling to reduce inflammation and enhance myelin repair. Learn more about Quanterix’s highly sensitive IFN-α, Multi-Subtype assay for #MultipleSclerosis research ➡️

🧬 Tailored Treatment for a Better Tomorrow 💊 After a stroke or TIA, getting the right treatment is crucial. With CYP219 genotype testing, we can now tailor clopidogrel therapy to match your unique genetic profile. This innovative approach ensures that your medication works as effectively as possible, reducing the risk of complications and paving the way for a smoother recovery. No more one-size-fits-all—just precision medicine that’s made for you. Discover the future of stroke care today! 🌟 To know more : ( https://lnkd.in/gFwdGF3Q ) #GeneticTesting #StrokeRecovery #PersonalizedMedicine #CYP219

In this single-center prospective case-control study, the findings illuminate the association between thromboembolism, pyoderma gangrenosum, and subsequent wound healing outcomes. https://ja.ma/3W6sdsD

𝓢𝓽𝓪𝓷𝓭𝓯𝓸𝓻𝓭 𝓜𝓮𝓭𝓲𝓬𝓲𝓷𝓮 "𝓢𝓽𝓪𝓷𝓯𝓸𝓻𝓭 𝓤𝓷𝓲𝓿𝓮𝓻𝓼𝓲𝓽𝔂 𝓢𝓬𝓱𝓸𝓸𝓵 𝓸𝓯 𝓜𝓮𝓭𝓲𝓬𝓲𝓷𝓮 " on the topic "Congenital Hypothyroidism: What Every Primary Care Provider Needs to Know" In this course we have learnt about the clinical signs of hypothyroidism, the initial work up, appropriate dosing and delivery of thyroid hormone replacement, the schedule of lab testing to monitor treatment and how to interpret results. The impact of congenital hypothyroidism on growth and development was studied in this course.

In recent years, there has been a rising interest in combination therapy’s potential to bring relief for refractory IBD patients or those with extraintestinal manifestations (EIMs). In the second part of our series "Dual Approaches, Added Challenges," we dive into the history of combination therapy in IBD and how that has impacted current development. Read part 2 here: https://bit.ly/4gML4kr

SHIP-CT study is a major milestone clearly demonstrating that imaging-based quantification can precisely assess treatment efficacy. The study was conducted in children with cystic fibrosis, using chest CT as the primary outcome measure. This external validation proves the specificity and high-precision sensitivity of LungQ™ Bronchus-Artery (BA) for an objective quantification of bronchial wall thickening and bronchial widening, as well as its importance for the assessment of a treatment effect. Read the full publication: https://lnkd.in/eQ-7iaq5

At #ASCO24, Bailey Nelson, MD, and team submit findings on the impact of whole pelvis radiation therapy (WPRT) on gut microbiota and chronic GI toxicity. The study highlights that patients with higher levels of Akkermansia muciniphila, a mucin-degrading bacteria, experience milder GI symptoms post-radiation. This discovery shows the potential for radioprotective gut bacteria therapies to enhance patients' quality of life. Read the full abstract: https://lnkd.in/gikMardV #CancerResearch #GutHealth